P

COPD Clinical Trials & the Real World: Critical Errors With COPD Inhalers, Triple Therapy, and the Hawthorne Effect

By Paul Jones
317 views
August 17, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

05:09
Merck

Risk and Severity of Pneumococcal Disease in Adults

Featured Video

04:42
Merck

Epidemiology and Serotypes Associated With Invasive Pneumococcal Dis…

Related Content

AUTOPLAY
17:28
Antonio Anzueto

2023 COPD Guidelines Update

17:25
Temple Lung Center

GOLD Standards: What You Need to Know

Feat. G. Criner
23:56
Aaron Baugh

ATS 2022: Before We Can Run - Racial Health Disparities in Lung Dise…

16:07
National Jewish Health

Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, …

Feat. J. P. Woodrow
17:03
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Asthma-COPD Overlap: Why is this Overlap a Problem?

Feat. B. Celli
23:33
CHEST 2022 Coverage

Inhaler Selection in COPD

Feat. D. Mahler
12:55
National Jewish Health

Nontuberculous Mycobacterial Lung Disease: Epidemiology and Overview

Feat. S. Kasperbauer, D. Griffith
09:48
Stephen Brunton

COPD: Dual Vs. Triple Therapy

33:54
Michigan Medicine

Management of Chronic Respiratory Failure With Non-Invasive Ventilat…

Feat. P. Choi
47:32
National Jewish Health

COPD 2024 and Beyond: Emerging Treatments

Feat. S. Lommatzsch
34:08
Michigan Medicine

Paradigm Shifts in Chronic Respiratory Failure

Feat. P. Choi
60:01
Michigan Medicine

The Multiple Faces of Asthma: When to Involve Your Specialist Collea…

Feat. N. Lugogo, A. Mohan, A. Kovalszki, R. Morrison
14:53
Allison Burbank

AAAAI 2022: Urban Air Pollutants - Inflammatory and Remodeling Effe…

16:44
Temple Lung Center

Lung Physiology: The Basics

Feat. L. Illipparambil
18:24
CHEST 2021 Coverage

CHEST 2021: Outpatient Management of Pneumothorax

Feat. D. Yu
13:56
Anna Blumental-Perry

ATS 2022: Dysregulation of Unfolded Protein Response (UPR) Signaling…

29:55
Jill Ohar

GOLD 2023 Update: Implications for Clinical Practice

11:24
Luis Puente-Maestu

MV130, a Sublingual Bacterial Immunotherapy to Prevent COPD Exacerba…

13:43
CHEST 2023 Insights

CHEST 2023 Insights: COPD - New Diagnostic Paradigm

Feat. B. Make
49:50
University of Colorado Department of Medicine

Contributions of Environmental and Social Determinants to Health Dis…

Feat. N. Hansel